Repligen (RGEN)
(Real Time Quote from BATS)
$120.80 USD
-0.02 (-0.02%)
Updated Jul 10, 2024 03:28 PM ET
3-Hold of 5 3
D Value F Growth B Momentum D VGM
Brokerage Reports
Repligen Corporation [RGEN]
Reports for Purchase
Showing records 181 - 200 ( 207 total )
Company: Repligen Corporation
Industry: Medical - Biomedical and Genetics
Company: Repligen Corporation
Industry: Medical - Biomedical and Genetics
The Week Ahead in Life Sciences - Upcoming Events for the Week of June 17This report contains brief updates on the following: PCYC, LGND, ONXX, RGEN, ANAC, ARNA, ONCY, CRDC. These companies are covered in more detail in separate Daily Notes and/or Company Reports.
Provider: WEDBUSH SECURITIES INC.
Analyst: MOUSSATOS L
Company: Repligen Corporation
Industry: Medical - Biomedical and Genetics
Termination of Coverage
Provider: RODMAN & RENSHAW, CO.
Company: Repligen Corporation
Industry: Medical - Biomedical and Genetics
Termination of Coverage
Provider: RODMAN & RENSHAW, CO.
Company: Repligen Corporation
Industry: Medical - Biomedical and Genetics
Preliminary Results - Incorporating the Novozymes Acquisition
Provider: RODMAN & RENSHAW, CO.
Analyst: PIROS E
Company: Repligen Corporation
Industry: Medical - Biomedical and Genetics
Preliminary Results - Incorporating the Novozymes Acquisition
Provider: RODMAN & RENSHAW, CO.
Analyst: PIROS E
Company: Repligen Corporation
Industry: Medical - Biomedical and Genetics
MORNING SUMMARY
Provider: RODMAN & RENSHAW, CO.
Company: Repligen Corporation
Industry: Medical - Biomedical and Genetics
Company: Repligen Corporation
Industry: Medical - Biomedical and Genetics
Company: Repligen Corporation
Industry: Medical - Biomedical and Genetics
MORNING SUMMARY
Provider: RODMAN & RENSHAW, CO.
Company: Repligen Corporation
Industry: Medical - Biomedical and Genetics
Company: Repligen Corporation
Industry: Medical - Biomedical and Genetics
Company: Repligen Corporation
Industry: Medical - Biomedical and Genetics
MORNING SUMMARY
Provider: RODMAN & RENSHAW, CO.
Company: Repligen Corporation
Industry: Medical - Biomedical and Genetics
BIPOLAR DRUG FAILS IN MID-STAGE DEVELOPMENT - LOWERING RATING
Provider: RODMAN & RENSHAW, CO.
Analyst: PIROS E
Company: Repligen Corporation
Industry: Medical - Biomedical and Genetics
Company: Repligen Corporation
Industry: Medical - Biomedical and Genetics
MONTHLY PORTFOLIO UPDATE - ELEMER PIROS AND BORIS PEAKER
Provider: RODMAN & RENSHAW, CO.
Analyst: PIROS E
Company: Repligen Corporation
Industry: Medical - Biomedical and Genetics
Company: Repligen Corporation
Industry: Medical - Biomedical and Genetics
Company: Repligen Corporation
Industry: Medical - Biomedical and Genetics
MORNING SUMMARY.
Provider: RODMAN & RENSHAW, CO.